Skip to main content

Open Access Autoimmune Thyroiditis and Iodine Therapy

Download Article:
 Download
(HTML 39.8 kb)
 
or
 Download
(PDF 397.4 kb)
 
The incidence of Hashimoto’s thyroiditis, also referred to as goitrous autoimmune thyroiditis, is estimated to be equivalent to that of Grave’s disease. Although first discovered one hundred years ago, the pathophysiology of this disease has not yet been completely defined. Patients present with varying degrees of symptoms and may present euthyroid. Studies have found associations between genetic predisposition, environmental factors and co-occurrence of other autoimmune disorders within patients with autoimmune thyroiditis. This has further impeded advances to clearly define the mechanisms associated with autoimmune thyroiditis as there are a number of potential confounding factors which are not shared by all patients. Concern has been raised suggesting that iodination of salt led to the emergence or increase in prevalence of autoimmune thyroiditis. In regions where chronic excess consumption of iodine occurs, studies have not found an association between iodine intake and prevalence of this disorder. Furthermore, autoimmune thyroiditis patients with low thyroid levels of iodine are at risk of developing hypothyroidism. Therefore iodine therapy is indicated in patients with autoimmune thyroiditis to preserve normal function of the thyroid, unless the patient has goiter. Patients receiving iodine therapy must be monitored closely to ensure the condition does not exacerbate.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Autoimmune thyroiditis; Hashimoto’s thyroiditis; Hypothyroidism; Iodine therapy

Document Type: Research Article

Publication date: 01 October 2013

More about this publication?
  • JRM is a peer-reviewed medical journal published annually by AARM. It publishes original research, reviews, and editorials that contribute to the understanding of nutritional and botanical influence on underlying mechanisms of chronic illness. The journal was established by Michaël Friedman, ND as the founding editor. The journal's current editor-in-chief is Liz Sutherland, ND of National University of Natural Medicine.
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Terms & Conditions
  • Certification Exam
  • CME conferences
  • CME webinars
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more